Treasury Blacklists More Folks: Hands Off Their U.S. Cash
Published Date: 8/26/2025
Notice
Summary
The U.S. Treasury’s OFAC just added new people to its blacklist, meaning their money and property in the U.S. are frozen. Americans can’t do business with these folks anymore. This move helps keep bad actors out of the U.S. financial system, and it’s effective immediately.
Analyzed Economic Effects
1 provisions identified: 0 benefits, 1 costs, 0 mixed.
New OFAC SDN Listings Freeze Assets
The Treasury’s OFAC added one or more people to the Specially Designated Nationals and Blocked Persons (SDN) List. All of those persons’ property and interests in property subject to U.S. jurisdiction are blocked, and U.S. persons are generally prohibited from engaging in transactions with them. This action is effective immediately.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-22864, Notice of OFAC Sanctions Action
On April 15, 2026, the U.S. Treasury’s Office of Foreign Assets Control (OFAC) blocked certain people and ships by adding them to a special list. This means any money or property they have under U.S. control is frozen, and Americans can’t do business with them. These actions help keep bad actors from using U.S. resources and protect national security.
2026-22861, Notice of OFAC Sanctions Action
The U.S. Treasury’s OFAC just blocked the property of certain people linked to a big criminal group and cyber crimes. This means Americans can’t do business with them anymore, starting November 5, 2026. If you have money or deals with these folks, it’s time to freeze those assets and cut ties fast!
2026-22862, Notice of OFAC Sanctions Action
The U.S. Treasury’s OFAC just blocked property linked to Han Yu Song, a North Korean individual tied to a banned financial group. This means U.S. people and businesses can’t deal with him or his assets starting October 28, 2026. It’s a clear move to stop money and support flowing to risky North Korean operations.
2026-22766, Notice of OFAC Sanctions Action
The U.S. Treasury’s OFAC just blocked two people from India, Ashwani Kumar Dhiman and Jaspreet Preeti Shahid, because they’re linked to companies involved with Iran. This means any money or property they have under U.S. control is frozen, and Americans can’t do business with them. The action started on November 4, 2026, so watch out for these new restrictions!
2026-22802, Notice of OFAC Sanctions Actions
The U.S. Treasury’s OFAC updated its sanctions lists on November 4, 2026, adding new details about people and groups tied to Iran under the EO13902 program. These updates mean certain individuals and entities now face stricter financial restrictions, blocking their access to U.S. money and markets. If you’re involved with these names, watch out—these changes could impact your business or transactions immediately.
2026-21944, Notice of OFAC Sanctions Action
On July 14, 2026, OFAC blocked the property and interests of certain people and ships, including the Iranian vessels Arkanoor 2 and Arkanoor 3, because they’re linked to sanctioned companies. This means U.S. folks can’t do business with them, and any assets they have under U.S. control are frozen. These actions help keep the financial system safe and signal serious consequences for breaking the rules.
Previous / Next Documents
Previous: 2025-16226, National Human Genome Research Institute; Amended Notice of Meeting
The National Human Genome Research Institute changed the meeting time for its advisory council on September 16, 2025. The meeting now starts at 9:30 a.m. and ends at 2:30 p.m., instead of the original 9:00 a.m. to 1:00 p.m. This update affects anyone interested in attending or following the meeting, with no changes to costs or location.
Next: 2025-16265, Determination of Regulatory Review Period for Purposes of Patent Extension; IQIRVO
The FDA has officially set the review period for IQIRVO, a human drug product, so its patent can be extended. This helps the company behind IQIRVO get extra time to protect their invention after going through the FDA’s approval process. If you’re involved in drug patents or development, this means important deadlines and opportunities to keep an invention exclusive just got clearer.